The global Alzheimer’s Therapeutics Market Share was valued at USD 3.78 billion in 2023 and is expected to reach USD 13.42 billion by 2032, representing a robust Compound Annual Growth Rate (CAGR) of 15.14% over the forecast period from 2024 to 2032.
Alzheimer’s disease is a progressive neurodegenerative disorder that significantly impacts the lives of millions of individuals...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian